GlassScriptPhysician profile
Michelle Gaa Ortega
NPI 1073531547
$1,770.13
in general payments reported to CMS, 2019-2025
17 companies · $787 in 2025
The $787 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $173 · 2023: $317 · 2024: $494 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.29 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $430.12 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.85 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $179.84 | 2023-2025 | Fasenra, Breztri, Airsupra |
| Actelion Pharmaceuticals US, INC. | $148.81 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Janssen Biotech, INC. | $145.59 | 2022-2023 | Simponi, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $124.26 | 2024 | Dupixent |
| Philips North America LLC | $114.91 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| United Therapeutics Corporation | $100.60 | 2025 | |
| Abbott Laboratories | $95.51 | 2023 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.32 | 2022 | |
| Insmed, INC. | $43.28 | 2025 | Arikayce |
| Inspire Medical Systems, INC. | $27.55 | 2023 | Inspire |
| Shionogi INC | $23.84 | 2025 | Fetroja |
| Verona Pharma, INC. | $23.25 | 2025 | Ohtuvayre |
| Amgen INC. | $17.52 | 2025 | Tezspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $14.93 | 2022 | |
| Boston Scientific Corporation | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.